Business Update30 Aug 2024, 08:33 pm
SYNCOM Formulations to Begin Manufacturing and Marketing of Generic Products
AI Summary
SYNCOM Formulations (India) Ltd. has announced a strategic decision to alter its operational model for the retail business segment. The company, which previously conducted its retail business through third-party arrangements, will commence manufacturing and marketing of generic products themselves. This change is expected to enhance market presence, increase sales volume, and improve control over product quality, pricing, and market reach, thereby positively impacting overall revenue from the domestic market.
Key Highlights
- SYNCOM Formulations to commence manufacturing and marketing of generic products themselves
- Strategic decision aimed at enhancing market presence and increasing sales volume in the domestic market
- Change expected to improve control over product quality, pricing, and market reach
- Move likely to positively impact overall revenue from the domestic market
- Change to be effective from tentatively 1 September, 2024